Company news
Recordati S.p.A. news in 2026
Recordati S.p.A.'s news releases, calls and decks from 2026, newest first.
Recordati announces the winner of the 12th edition of the Arrigo Recordati Prize for scientific research
September 17, 2026
Palliser Capital Issues Letter to Recordati’s Board of Directors Urging Withdrawal of Support on Materially Undervalued Tender Offer
September 14, 2026
Recordati: solid momentum of the group continues first half 2026. net revenue +6.6%, EBITDA +8.8%, Adjusted Net income +6.7%
July 28, 2026
Recordati celebrates its first 100 years at triennale milano with an exhibition revealing objects and images from its historical archive for the first time
June 16, 2026
First Quarter Report 2026
May 14, 2026
Recordati: strong momentum of the group continues into the first quarter of 2026 net revenue +4.9%, EBITDA(1) +5.0%, Adjusted net income(2) +7.2%
May 12, 2026
1 April 2026 - Financial Statements of Recordati S.p.A. at 31 December 2025 and related Report of the Auditing Firm
April 1, 2026
Recordati reports strong preliminary full year 2025 results: revenue +11.8%, EBITDA(1) +14.5%, Adjusted net income(2) +14.5%
February 17, 2026
Recordati reports strong preliminary full year 2025 results: revenue 11.8%, EBITDA 14.5%, Adjusted net income 14.5%
February 17, 2026
Recordati announces strategic collaboration with Moderna to develop and commercialize worldwide mRNA 3927 for the treatment of propionic acidemia
January 29, 2026
14 January 2026 - J.P. Morgan Healthcare Conference Presentation
January 14, 2026
Calls in 2026
Decks in 2026
- Recordati Industria Chimica e Farmaceutica — H1 2026 Earnings Presentation
Earnings · 22 slides · Jul 29, 2026
- Recordati Industria Chimica e Farmaceutica — Q1 2026 Earnings Presentation
Earnings · 25 slides · May 13, 2026
- Recordati Industria Chimica e Farmaceutica — FY2025 Earnings Presentation
Earnings · 25 slides · Feb 18, 2026
- J.P. Morgan Healthcare Conference 2026
Conference · 13 slides · Jan 14, 2026